Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(12/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(12/week)
News
United States
(633/week)
Manufacturing
(426/week)
Energy
(356/week)
Technology
(446/week)
Other Manufacturing
(359/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Hunter syndrome
Dec 18, 2019
REGENXBIO Announces Interim Data from Phase I/II Trial of RGX-121 for the Treatment of Mucopolysaccharidosis Type II (MPS II)
Dec 04, 2019
Hunter Syndrome Treatment Market Size, Share & Trend Analysis By Treatment, By Region And Segment Forecasts, 2019 - 2026
Oct 23, 2019
Allievex Completes Series A Financing Led by Pappas Capital and Novo Holdings
Jul 03, 2019
Mucopolysaccharidosis (MPS) Treatment Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
Apr 03, 2019
Clinigen K.K. and GC Pharma Announce Exclusive Licensing Agreement in Japan for Hunterase (Idursulfase-beta) ICV, Hunter Syndrome Drug
Feb 07, 2019
Sangamo Announces Interim Results Of Phase 1/2 CHAMPIONS Study Showing Preliminary Evidence Of In Vivo Genome Editing In Patients With MPS II Treated With SB-913
Sep 05, 2018
Sangamo Announces 16 Week Clinical Results Including Reductions In Glycosaminoglycans In Phase 1/2 Trial Evaluating SB-913, A Zinc Finger Nuclease Genome Editing Treatment For MPS II (Hunter Syndrome)
Aug 17, 2018
2018 Mucopolysaccharidosis Disorders Drug Development Pipeline Review
Aug 10, 2018
First Patient Dosed in Phase 1/2 Study Evaluating SOBI003 for Treatment of Mucopolysaccharidosis Type IIIA (MPS IIIA)
Aug 02, 2018
ArmaGen Receives U.S. Orphan Drug Designation for AGT-184
Jul 27, 2018
Sangamo To Host Educational Webcast With Hunter Syndrome (MPS II) Expert, Joseph Muenzer, M.D., Ph.D.
Jul 10, 2018
ArmaGen's AGT-181 52-Week Phase 1/2 Proof-of-Concept Study Results Published in Orphanet Journal of Rare Diseases
May 15, 2018
REGENXBIO Joins the Mucopolysaccharidosis Community to Advance Research and Innovation
May 02, 2018
REGENXBIO Receives FDA Fast Track Designation for RGX-121 Gene Therapy for the Treatment of Mucopolysaccharidosis Type II
Apr 04, 2018
Sangamo Announces Publication In Molecular Therapy Of Preclinical Study Data From MPS II In Vivo Genome Editing Program
Feb 08, 2018
ArmaGen's AGT-181 Demonstrates Neurocognitive Benefit in Children with Severe MPS I
Feb 06, 2018
Sangamo Therapeutics Presents Initial Safety Data from CHAMPIONS Genome Editing Study for MPS II at WORLDSymposium
Nov 30, 2017
ArmaGen's AGT-181 Granted Fast Track Designation for the Treatment of Hurler Syndrome (MPS I)
Sep 06, 2017
BioMarin Presents Interim Data of Phase 1/2 Study of BMN 250 for Treatment of Sanfilippo B Syndrome (MPS IIIB) at 13th International Congress of Inborn Errors of Metabolism (ICIEM) 2017
Jun 15, 2017
Mucopolysaccharidosis III - Pipeline Review, H1 2017
Latest News
May 10, 2024
SPINNOVA® Fibre Manufacturer Woodspin Awarded FSC® Chain of Custody Certification
May 10, 2024
CRH Q1 2024 Results
May 10, 2024
Hafnia’s Q1 2024 Financial Results Presentation to Be Held on 15 May 2024
May 10, 2024
San Luis Obispo electrician answers 'Home or public EV charging, which is best?'
May 10, 2024
Bracer™ –new Android Application for Position Location Information
May 10, 2024
Lockheed Martin Awarded $451 Million To Upgrade Additional US Army And International M270 Launchers
May 10, 2024
Karen Norheim, Penn State Great Valley Alumna, Wins the Diamonds of the Decades Award
May 10, 2024
GeoPark Signs New Offtake Agreement With Vitol for the Llanos 34 Block in Colombia
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events